Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine ESP Block in Upper Abdominal Cancer Surgery
NCT04315454Phase 1Unknown
- Sponsor
- South Egypt Cancer Institute
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms), sponsored by South Egypt Cancer Institute. Primary endpoint: Morphine Consumption at 24 hours. Status: unknown.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04315454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315454.